Ledger.Open graph →
SEC Form D · filed March 27, 2019

ContraVir Pharmaceuticals, Inc

Offering
$1.3M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Edison, NJ
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Gary S. Jacob · Edison, NJDirectorJohn P. Cavan · Edison, NJExecTimothy P. Block · Edison, NJDirectorRobert Foster · Edison, NJExec · DirectorJohn P. Brancaccio · Edison, NJDirectorArnold P. Lippa · Edison, NJDirectorReof Manager, LLC · Buford, GADirectorPanos Ninios · Westport, CTDirectorJingqiu Mei · skokie, ILExecMichael A. Compisi · Rochester, NYDirectorBruce Wiegand · Westport, CTDirectorAnn Lamont · Nashville, TNExec · DirectorThomas P. Adams · Edison, NJDirectorJohn M. Cowell · Penn Yan, NYDirectorDennis A. Buchan · Rochester, NYDirectorScott S. Dakers · Grand Cayman, Cayman IslandsDirectorVincent S. Maddi · New York, NYDirectorShawn M. Brennan · New York, NYExecJoel Kosakoff · Del Mar, CAExec · DirectorThomas P. Adams · Edison, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗